Use App
Trending
News
Earnings
Newsletters
Work With Us
All
DIA
0.04%
SPY
0.05%
QQQ
0.02%
Trending
CAW
8.55%
OCUL
23.66%
HBAR
12.20%
SATOSHI
6.76%
BYTE
1.03%
TOSHI
15.43%
UPB
31.09%
ACHR
0.59%
SWFTC
3.39%
DRS
0.61%
CAW
8.55%
OCUL
23.66%
HBAR
12.20%
SATOSHI
6.76%
BYTE
1.03%
TOSHI
15.43%
UPB
31.09%
ACHR
0.59%
SWFTC
3.39%
DRS
0.61%
home
Symbol
LLYX
LLYX
Defiance Daily Target 2X Long LLY ETF
114
Volume
277,822.00
52W High
$28.44
52W Low
$9.60
50D MA
$24.38
Prev Close
$22.79
Loading...
Loading...
Feed
News
Sentiment
Fundamentals
Info
News
all
press releases
LLY Stock Surges On Q4 Beat – Obesity, Diabetes Drugs Drive Strong FY26 Outlook
Fourth-quarter revenue surged 43% to $19.3 billion, above Street estimates of $17.86 billion, according to Fiscal.ai data.
Stocktwits
·
10d ago
Full Article
FDA Clears Popular Weight-Loss Drugs Of Suicide Risk After Review Of Over 100K Patients, Asks Drugmakers To Remove Warnings
The request applies to GLP-1 RAs approved for obesity, including Novo Nordisk’s Wegovy and Saxenda and Eli Lilly’s Zepbound.
Stocktwits
·
1mo ago
Full Article
<
...
1
>
Latest LLYX News
View
Top Discussions
top
active
trending
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile